Market Cap: $7.98B
Market Cap: $7.98B
Open
$9.75
Prev. Close
$13.26
High
$9.76
Low
$9.75
Sysmex Corporation, headquartered in Kobe, Japan, is a prominent developer, manufacturer, and distributor of diagnostic instruments, reagents, and specialized software. The company's extensive offerings cater to diverse medical needs, including hematology, where it provides three-part and five-part white blood cell differentiation instruments, alongside high-volume testing transport systems for laboratories.
Sysmex Corporation trades on the Other OTC under the ticker SSMXY, priced in USD.
Sysmex Corporation has a market capitalisation of $7.98B, based on its latest share price.
SSMXY trades at 30.36 times its trailing 12-month earnings.
Over the past 52 weeks SSMXY has traded between $8.01 and $13.75.
Yes. Sysmex Corporation's dividend yields 2.01% at the current share price, paying out 60% of its earnings.
Profitable, with a net margin of 7.5% over the last 12 months.
The analyst consensus rating for SSMXY is Hold.
Hisashi Ietsugu is the CEO of Sysmex Corporation, which is headquartered in Kobe.
Generated automatically from reported financial data. General information only, not financial advice.